Redundant pathways for removal of defective RNA polymerase II complexes at a promoter-proximal pause checkpoint
The biological purpose of Integrator and RNA polymerase II (RNAPII) promoter-proximal pausing remains uncertain. Here, we show that loss of INTS6 in human cells results in increased interaction of RNAPII with proteins that can mediate its dissociation from the DNA template, including the CRL3<sup>ARMC5</sup> E3 ligase, which ubiquitylates CTD serine<sub>5</sub>-phosphorylated RPB1 for degradation. ARMC5-dependent RNAPII ubiquitylation is activated by defects in factors acting at the promoter-proximal pause, including Integrator, DSIF, and capping enzyme. This ARMC5 checkpoint normally curtails a sizeable fraction of RNAPII transcription, and ARMC5 knockout cells produce more uncapped transcripts. When both the Integrator and CRL3<sup>ARMC5</sup> turnover mechanisms are compromised, cell growth ceases and RNAPII with high pausing propensity disperses from the promoter-proximal pause site into the gene body. These data support a model in which CRL3<sup>ARMC5</sup> functions alongside Integrator in a checkpoint mechanism that removes faulty RNAPII complexes at promoter-proximal pause sites to safeguard transcription integrity.
Authors
- Richard Mitter (ORCID: https://orcid.org/0000-0002-1279-3760)
- Ryan M. Sheridan (ORCID: https://orcid.org/0000-0003-4012-3147)
- Jesper Q. Svejstrup (ORCID: https://orcid.org/0000-0003-4964-6147)
- David L. Bentley (ORCID: https://orcid.org/0000-0002-8414-4647)
- Nova Fong
- A. Barbara Dirac-Svejstrup (ORCID: https://orcid.org/0000-0003-0341-6944)
- Daniel Blears (ORCID: https://orcid.org/0000-0002-2421-0403)
- Dandan He (ORCID: https://orcid.org/0000-0002-1536-6465)
- Jiangman Lou
Institutions
- University of Copenhagen (DK)
- The Francis Crick Institute (GB)
- University of Colorado Denver (US)
Publication Details
- Journal
- Molecular Cell
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1016/j.molcel.2024.10.012
- Citations
- 21
- Primary Topic
- Genomics and Chromatin Dynamics
- Type
- article
- Field-Weighted Citation Impact
- 4.91
Funders
- Wellcome Trust
- Francis Crick Institute
- Cancer Research UK
- National Research Foundation
- Danmarks Grundforskningsfond
- Novo Nordisk
- Novo Nordisk Fonden
- National Institutes of Health
- University of Colorado Denver
- Medical Research Council